Viewing Study NCT02433158

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-21 @ 1:55 AM
Study NCT ID: NCT02433158
Status: TERMINATED
Last Update Posted: 2021-02-10
First Post: 2015-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease
Sponsor: GlycoMimetics Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Anemia View
None Sickle Cell Disease View
None Sickle Cell Disorders View
None Pain Crisis View
None Vaso-occlusive Crisis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rivipansel View
None GMI-1070 View
None Selectin Inhibitor View
None SCD View
None VOC View